Foghorn Therapeutics Inc. (FHTX) Executive Compensation
Foghorn Therapeutics Inc. (FHTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: FHTX
CIK: 1822462
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerBrian Emrick
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 3 | 2026-10-05 | 2026-10-01 | OWNERSHIP DOCUMENT | 0000921895-26-002730 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-10-05 | — | SCHEDULE 13G/A Filing | 0000921895-26-002729 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-09-25 | 8-K | 0001628280-26-064102 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001628280-26-053819 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001628280-26-053817 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001474056-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001970274-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001581956-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001972849-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001591109-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001197032-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001180763-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001073385-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-24 | PRIMARY DOCUMENT | 0001486373-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-06-24 | 2026-06-24 | 8-K | 0001628280-26-045154 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000921895-26-001393 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-14 | — | SCHEDULE 13G/A Filing | 0001193805-26-000608 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001628280-26-031671 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001628280-26-031669 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-001195 | View SEC Doc Filr Page |
| ARS | 2026-04-30 | 2025-12-31 | ARS | 0001193125-26-193958 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-30 | — | DEFA14A | 0001193125-26-193948 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-24 | DEF 14A | 0001193125-26-193928 | View SEC Doc Filr Page |
| 8-K | 2026-04-21 | 2026-04-21 | 8-K | 0001628280-26-026259 | View SEC Doc Filr Page |
| 4 | 2026-04-13 | 2026-04-09 | PRIMARY DOCUMENT | 0001828724-26-000005 | View SEC Doc Filr Page |